RFA
UTHR icon

Resurgent Financial Advisors’s United Therapeutics UTHR Stock Holding History

Resurgent Financial Advisors’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$519K Buy
958
+281
+42% +$158K 0.14% 159
2026
Q1 		$401K Buy
+677
New +$337K 0.15% 171
2023
Q1 		– Sell
-764
Closed -$212K – 629
2022
Q4 		$212K Sell
764
-197
-20% -$49.7K 0.11% 191
2022
Q3 		$201K Sell
961
-55
-5% -$12.3K 0.13% 191
2022
Q2 		$239K Buy
+1,016
New +$207K 0.15% 157

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Resurgent Financial Advisors's UTHR Position: Q2 2026 in Review

Resurgent Financial Advisors increased its United Therapeutics (UTHR) stake by 42% in Q2 2026, buying an estimated $158K and bringing the position to 958 shares worth $519K. The position accounts for 0.14% of the portfolio, ranked #159.

Resurgent Financial Advisors first reported a position in UTHR in Q2 2022 and has held it in 5 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Resurgent Financial Advisors held 958 shares of United Therapeutics worth $519K as of Q2 2026.
  • Resurgent Financial Advisors bought 281 United Therapeutics shares in Q2 2026, an estimated $158K.
  • United Therapeutics made up 0.14% of Resurgent Financial Advisors's portfolio in Q2 2026, its #159 holding.
  • Resurgent Financial Advisors first reported a position in United Therapeutics in Q2 2022 and has held it in 5 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Resurgent Financial Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.